Wockhardt Limited

Ethawk 125mg Injection 2ml

MRP ₹25.18 (Inclusive of all taxes)
Deliver to

Netmeds First Membership

Starting at just ₹[] for 3 months.
View Plans

Introduction About ETHAWK 125MG INJECTION

ETHAWK 125MG INJECTION contains Ethamsylate, which belongs to the group of medicines called Antihemorrhagic drugs. It is used to manage bleeding from the blood vessels and to manage bleeding before or after an operation.

Ethamsylate exerts hemostatic action by improving platelet adhesiveness and restoring capillary (blood vessels) resistance. It decreases bleeding time and increases platelet clumping which reduces capillary bleeding and improves capillary wall stability. Before the management, your doctor might want to do certain blood tests to understand your existing condition.

ETHAWK 125MG INJECTION is not recommended for use if you have porphyria (defect in the synthesis of haemoglobin) or bronchial asthma. Before receiving ETHAWK 125MG INJECTION inform your doctor if you have hypotension or unstable blood pressure. ETHAWK 125MG INJECTION should be used with caution in pregnant women. It is not recommended for use in breastfeeding women. Consult your doctor if you experience any unusual effects while receiving ETHAWK 125MG INJECTION.

Uses Of ETHAWK 125MG INJECTION

  • Prevents and manages bleeding from the blood vessels
  • Prevent bleeding before or after an operation

How ETHAWK 125MG INJECTION Works

ETHAWK 125MG INJECTION exerts hemostatic action by improving platelet adhesiveness and restoring capillary (blood vessels) resistance. It decreases bleeding time and increases platelet clumping which reduces capillary bleeding and improves capillary wall stability. It inhibits PGI-2 synthesis and corrects abnormal platelet function.

How to use ETHAWK 125MG INJECTION

ETHAWK 125MG INJECTION will be given to you only by a doctor or a nurse into the muscles (intramuscularly) or the veins (intravenously). Your doctor will decide the right dose and duration depending on your age, body weight and disease condition.

Warning & Precautions

Pregnancy

ETHAWK 125MG INJECTION should be used with caution in pregnant women or if you are planning to have a baby. Consult your doctor before receiving it.

Breastfeeding

ETHAWK 125MG INJECTION is not recommended for use in breastfeeding women as it is unknown if the medicine is excreted in breast milk. Consult your doctor before receiving it.

Allergy

Do not receive ETHAWK 125MG INJECTION if you are allergic to Ethamsylate or any other ingredients of this medicine.

Lungs

ETHAWK 125MG INJECTION is not recommended for use in patients with bronchial asthma. Consult your doctor before receiving ETHAWK 125MG INJECTION.

Heart Disease

ETHAWK 125MG INJECTION should be used with caution in patients with hypotension and unstable blood pressure. Consult your doctor before receiving ETHAWK 125MG INJECTION.

Others

ETHAWK 125MG INJECTION is not recommended for use if you:

  • have porphyria (defect in the synthesis of haemoglobin)

Interactions

A. Drug-Drug interactions:

Before receiving ETHAWK 125MG INJECTION, inform your doctor if you are taking any prescription, nonprescription or herbal medicines.

Overdosage:

ETHAWK 125MG INJECTION will be administered to you only by a doctor or a nurse in a hospital, so it is unlikely to receive an overdose. However, consult your doctor or nurse if you experience any unusual symptoms.

Synopsis

Drug :   Ethamsylate
Pharmacological Category :   Antihemorrhagic agent
Therapeutic Indication :   Bleeding from blood vessels, perioperative bleeding
Dosage Forms :   Tablet, Injection

More Information

  • Keep ETHAWK 125MG INJECTION out of reach from children
  • Store below 30°C

FAQs About ETHAWK 125MG INJECTION

What is ETHAWK 125MG INJECTION used for?

ETHAWK 125MG INJECTION contains Ethamsylate which belongs to the group of medicines called Antihemorrhagic drugs. It is used to manage bleeding from the blood vessels and to manage bleeding before or after an operation.

Can ETHAWK 125MG INJECTION be received by pregnant or breastfeeding women?

ETHAWK 125MG INJECTION is not recommended for use in breastfeeding women. And it should be used with caution in pregnant women or women planning to have a baby. Consult your doctor before receiving ETHAWK 125MG INJECTION.

How ETHAWK 125MG INJECTION works?

It exerts hemostatic action by improving platelet adhesiveness and restoring capillary (blood vessels) resistance. It decreases bleeding time and increases platelet clumping which reduces capillary bleeding and improves capillary wall stability. It inhibits PGI-2 synthesis and corrects abnormal platelet function.

When is ETHAWK 125MG INJECTION contraindicated?

ETHAWK 125MG INJECTION is not recommended for use in patients with hypersensitivity to this medicine, porphyria (defect in the synthesis of haemoglobin) and bronchial asthma. Consult your doctor for more information.

Can ETHAWK 125MG INJECTION be used in patients with heart problems?

ETHAWK 125MG INJECTION should be used with caution in patients with hypotension and unstable blood pressure. Consult your doctor for more information on duration and dosage before receiving ETHAWK 125MG INJECTION.

References

1. KD Tripathi. Drugs Affecting Coagulation, Bleeding and Thrombosis. Essentials of medical pharmacology. Eighth Edition. 2019. Page –662.

2. Ricardo P Garay, Carlo Chiavaroli, Patrick Hannaert. Article name. Therapeutic efficacy and mechanism of action of ethamsylate, a long-standing hemostatic agent. National library of medicine, National center for biotechnology information. Pubmed.gov 2006 [Accessed on 9th July 2022] https://pubmed.ncbi.nlm.nih.gov/16772766/

3. M.E.IMorgan I.W.TBenson JBenson R.W.I Cooke. Ethamsylate reduces the incidence of periventricular haemorrhage in very low birthweight babies. The lancet 1981. [Accessed on 9th July 2022] https://www.sciencedirect.com/science/article/abs/pii/S014067368191103X

4. Ethamsylate. CIMS. [Accessed on 9th July 2022] https://www.mims.com/india/drug/info/etamsylate?type=full&mtype=generic

Useful Diagnostic Tests

  • Blood tests

Author Details

Written By Dr. Dhivakaran R - BDS
Reviewed For Accuracy By Dr. Venkatesh Poludasu - MBBS
Last updated on 09 Nov 2022 | 04:57 PM(IST)
Lab updated